Drabiak’s Articles

Drabiak, Roundup Litigation: Using Discovery to Dissolve Doubt, under review for publication.

Drabiak, The Nuffield Council’s Green Light for Genome Editing Defies Fundamental Human Rights Law, under review for publication.

Drabiak, Expanding Medication Assisted Treatment is Not the Answer: Flaws in the Substance Abuse Treatment Paradigm, 21(1) Journal of Health Care Law, forthcoming Spring 2019.

Drabiak, Untangling the Promises of Human Genome Editing, 46 Journal of Law, Medicine & Ethics 991-1009 (2018).

Drabiak, Emerging Governance of Mitochondrial Replacement Therapy: Assessing Coherence Between Scientific Evidence and Policy Outcomes, 20(1) Journal of Health Care Law 1-61(2018).

Drabiak, Dying to Be Fresh and Clean? Assessing Regulatory Shortcomings  Governing Personal Care Products, Cancer Risk, and Epigenetic Damage, 35 Pace Environmental Law Review 75-107 (2018).

Drabiak, The Impact of a Developing Regulatory Framework Governing LDTs in Precision Oncology: Re-envisioning the Clinical Risk Assessment Paradigm,   13 Journal of Health &  Biomedical Law 1-57 (2017).

Drabiak, Caveat Emptor: How the Intersection of Big Data and Consumer Genomics Exponentially Increases Informational Privacy Risks, 27 Health Matrix: Journal of Law-Medicine 153-184 (2017).

Drabiak, Challenging FDA’s Authority to Regulate Autologous Adult Stem Cells for Therapeutic Use: Celltex, Substantial Risks, and the Implications of US v. Regenerative Sciences, 23 Health Matrix: Journal of Law-Medicine, 493-535 (2013).

 Drabiak, New President, New hESC Research Policy:  Comparative International Perspectives and Embryonic Stem Cell Research Laws in France,  32 Biotechnology and Pharmaceutical Law Review 349-356 (2013).

Drabiak, Granular Control of EHRs to Overcome Fragmented Disclosure Law: How Policy Choices for  Granularity will Affect Clinical Care, Impact Secondary Use of Health Information, and Alter Risks for Patients and Providers, 10 Indiana Health Law Review 39-73 (2013).

 Drabiak, Sleep Deprived Physicians Considering Modafinil: Using a Controlled Substance For Cognitive Enhancement Gambles With Differential Drug Responses and Violates Ethical And Legal Duties Against Physician Impairment, 13 Journal of Health Care Law 339-366 (2011).

Drabiak, Waiving Informed Consent to Prenatal Screening and Diagnosis? Problems with Paradoxical Negotiation in Surrogacy Contracts, Currents in Contemporary Ethics,  39 Journal of Law, Medicine & Ethics 559-564 (2011).

Drabiak, Reining In The Pharmacological Enhancement Train: We Should Remain Vigilant About Regulatory Standards For Prescribing Controlled Substances, 39 Journal of Law, Medicine & Ethics 272-279 (2011).

Drabiak, Physicians Prescribing “Medicine” for Enhancement: Why We Should Not and Cannot Overlook Safety Concerns, Open Peer Commentary, 11 American Journal of Bioethics 17-19 (2011).

Drabiak, Lessons from Havasupai Tribe v. Arizona State University Board of Regents: Recognizing Group, Cultural, and Dignitary Harms as Legitimate Risks Warranting Integration into Research Practice, 6 Journal of Health & Biomedical Law 175-225 (2010).

 Drabiak, Legal Regulation of Banking Newborn Blood Spots for Research: How Bearder and Beleno Resolve the Question of Consent, 11 Houston Journal of Health Law & Policy 1-46 (2010).

Drabiak, Baby Gender Mentor: Class Action Litigation Calls Attention to a Deficient Federal Regulatory Framework for DTC Genetic Tests, Politicized State Statutory Construction, and a Lack of Informed Consent, 14 Michigan State University Journal of Medicine and Law 71-92 (2010).

Drabiak, Revisiting the USPTO’s Examination Guidelines for Gene Patents: Congressional Inaction, USPTO Restraint, and Judicial Remedy, 6 Journal of International Biotechnology Law 204-209 (2009).

Drabiak, State Codification of Federal Regulatory Ambiguities in Biobanking and Genetic Research: What Can We Learn from New Mexico and Minnesota?, 30 Journal of Legal Medicine 299-327 (2009).

Girod & Drabiak, A Proposal for Comprehensive Biobank Research Laws to Promote Translational Medicine in Indiana, 5 Indiana Health Law Review 217-250 (2008).

Morrell, Brown, Qi, Drabiak, Helft, The Do-Not-Resuscitate Order: Association with Advance Directives, Physician Specialty, and Documentation of Discussion 15 Years After the PSDA, 34 Journal of Medical Ethics 642-647 (2008).

Haas, Renbarger, Meslin, Drabiak, Flockhart, Patient Attitudes Toward Genotyping in an Urban Women’s Health Clinic, 112 Obstetrics and Gynecology 1023-1028 (2008).

Drabiak et al.,  Ethics, Law, and Commercial Surrogacy: A Call for Uniformity, 35 Journal of Law, Medicine & Ethics 300-309 (2007).

Book Chapter


Katherine Drabiak & Zachary Pruitt, Law and Ethics, in American Public Health Association Review Guide for Certified in Public Health Exam (Karen Liller & Jaime Corvin eds., 2018).

Websites and Blogs of Interest:

 Bioethics and Genomics

American Journal of Bioethics Blog

Center for Genetics and Society Biopolitcal Times


The Hasting Center for Bioethics Forum

Health Law

Harvard Law Bill of Health

Robinson Bradshaw & Hinson’s Genomics Law Report

Functional Medicine

Kelly Brogan, MD.  Holistic Women’s Health Psychiatrist.

Sara Gottfried, MD.  Integrative Physician for Women.

Mark Hyman, MD.  Integrative Physician.

Judith Orloff, MD.  Integrative Psychiatrist.

David Perlmutter, MD.  Integrative Neurologist.

Aviva Romm, MD.  Integrative Physician for Women and Children.

Andrew Weil, MD.  Integrative Physician.